Cookie Einstellungen
Diese Webseite verwendet ausschließlich notwendige Cookies, die für die Funktion erforderlich sind. Marketing- und Statistik-Cookies kommen nicht zum Einsatz. Weitere Informationen finden Sie in unserer Datenschutzerklärung.
 Notwendig   Details einblenden
      OK      
Bitte logge Dich ein, um diese Funktion zu nutzen!
      OK      
x

INTEGRA LIFESCIENCES Aktie

 >INTEGRA LIFE Aktienkurs 
8.275 EUR    (TradegateBSX)
Ask: 8.35 EUR / 2200 Stück
Bid: 8.2 EUR / 2200 Stück
Tagesumsatz: 0 Stück
Realtime Kurs von 7:30 bis 22 Uhr!
INTEGRA LIFE Aktie über LYNX handeln
>INTEGRA LIFE Performance
1 Woche: +1,5%
1 Monat: -9,1%
3 Monate: -22,7%
6 Monate: -34,3%
1 Jahr: -54,5%
laufendes Jahr: -23,4%
>INTEGRA LIFESCIENCES Aktie
Name:  INTEGRA LIFESCIENCES
Land:  USA
Sektor:  Gesundheit
ISIN/ Wkn:  US4579852082 / 897013
Symbol/ Ticker:  IL3 (Frankfurt) / IART (NASDAQ)
Kürzel:  FRA:IL3, ETR:IL3, IL3:GR, NASDAQ:IART
Index:  -
Webseite:  https://www.integralife.c..
Profil:  Integra LifeSciences Holdings Corporation is a global medical technology company specializing in innovative solutions for neurosurgery, tissue reconstruction, and ear, nose, and throat procedures. The company operates through two primary business seg..
>Volltext..
Marktkapitalisierung:  646.15 Mio. EUR
Unternehmenswert:  2152 Mio. EUR
Umsatz:  1416.64 Mio. EUR
EBITDA:  271.23 Mio. EUR
Nettogewinn:  -447.43 Mio. EUR
Gewinn je Aktie:  -5.83 EUR
Schulden:  1761.38 Mio. EUR
Liquide Mittel:  203.63 Mio. EUR
Operativer Cashflow:  43.65 Mio. EUR
Bargeldquote:  0.58
Umsatzwachstum:  -10.51%
Gewinnwachstum:  -6456.58%
Dividende je Aktie:  -
Dividendenrendite:  -
Dividendenschätzung:  -
Insiderhandel:  -
Suchwörter:  INTEGRA LIFESCIENCES, INTEGRA LIFE, INTEGRA LIFESCIENCE
Letzte Datenerhebung:  05.04.26
>INTEGRA LIFE Kennzahlen
Aktien/ Unternehmen:
Aktien: 77.94 Mio. St.
Frei handelbar: 85.55%
Rückkaufquote: -0.1%
Mitarbeiter: 4427
Umsatz/Mitarb.: 0.32 Mio. EUR
Analysten:
Analystenrating: Neutral
Kursziel: 73.24%
Bewertung:
KGV: -
KGV lG: 3.88
KUV: 0.44
KBV: 0.69
PEG-Ratio: -
EV/EBITDA: 7.93
Rentabilität:
Bruttomarge: 54.65%
Gewinnmarge: -31.58%
Operative Marge: 9.88%
Managementeffizenz:
Gesamtkaprendite: -13.52%
Eigenkaprendite: -39.9%
>INTEGRA LIFE Peer Group
Gesundheit, Medizinprodukte & -technik/ Implantate/ Wundpflege
 
27.02.26 - 17:30
Why Integra LifeSciences (IART) is a Top Momentum Stock for the Long-Term (Zacks)
 
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage....
26.02.26 - 23:00
Integra LifeSciences (IART) Earnings Transcript (Fool)
 
Um den gesamten Artikel unter fool.com zu lesen, klicken Sie bitte auf die Überschrift...
26.02.26 - 16:00
Integra LifeSciences (IART) Beats Q4 Earnings and Revenue Estimates (Zacks)
 
Integra (IART) delivered earnings and revenue surprises of +4.73% and +0.13%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?...
26.02.26 - 12:12
Integra LifeSciences Holdings Corporation Non-GAAP EPS of $0.83 beats by $0.03, revenue of $434.9M beats by $5.28M (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
26.02.26 - 12:03
Integra LifeSciences Reports Fourth Quarter and Full-Year 2025 Financial Results and Provides 2026 Financial Guidance (GlobeNewswire EN)
 
PRINCETON, N.J., Feb. 26, 2026 (GLOBE NEWSWIRE) --  Integra LifeSciences Holdings Corporation (NASDAQ: IART) today reported financial results for the fourth quarter and full year ended December 31, 2025....
09.02.26 - 12:36
Integra LifeSciences to Host Fourth Quarter and Full Year 2025 Financial Results Conference Call on February 26, 2026 (GlobeNewswire EN)
 
PRINCETON, N.J., Feb. 09, 2026 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, will release fourth quarter and full year 2025 financial results on Thursday, February 26, 2026, prior to the market open. In conjunction with the earnings release, Integra's management team will host a conference call at 8:30 a.m. ET....
04.02.26 - 15:06
Piper Sandler Companies Elects Stuart M. Essig to Board of Directors (Business Wire)
 
MINNEAPOLIS--(BUSINESS WIRE)--Piper Sandler Companies (NYSE: PIPR), a leading investment bank, is pleased to announce the addition of Stuart M. Essig, Ph.D. to its board of directors. “Stuart will be a great asset to our board of directors. He brings deep experience and knowledge of the healthcare and medical technology industries, which remain important sectors for our investment banking business. In addition, his proven track record of leading a growing, publicly traded company will provide valuable perspective to the board,” said Chad Abraham, Piper Sandler chairman and chief executive officer. Essig previously served as chief executive officer and director of Integra LifeSciences Corporation, a global medical technology company focused on innovative solutions for neurosurgery, tissue reconstruction, and advanced wound care, from 1997 to 2012. Following that, he has served as chairman from 2012 until today and executive chairman during 2024 and 2025. During Essig's tenure, Integra LifeSciences gre...
05.01.26 - 22:33
Integra LifeSciences Leadership to Present at the 44th Annual J.P. Morgan Healthcare Conference (GlobeNewswire EN)
 
PRINCETON, N.J., Jan. 05, 2026 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq: IART), a leading global medical technology company, today announced that chief executive officer Mojdeh Poul and chief financial officer Lea Knight will present at the 44th Annual J.P. Morgan Healthcare Conference on Wednesday, January 14, 2026 at 2:15 p.m ET or 11:15 a.m PT...
01.12.25 - 22:33
Integra LifeSciences Leadership to Present at the Citi 2025 Global Healthcare Conference (GlobeNewswire EN)
 
PRINCETON, N.J., Dec. 01, 2025 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq: IART), a leading global medical technology company, today announced that chief executive officer Mojdeh Poul and chief financial officer Lea Knight will present at the Citi 2025 Global Healthcare Conference on December 3, 2025 at 10:30 a.m ET...
25.11.25 - 14:33
Integra LifeSciences Welcomes Policy Advancements Supporting Medicare Beneficiary Access (GlobeNewswire EN)
 
Company to advance care through broader access to breadth of skin substitutes across four unique technology platforms Company to advance care through broader access to breadth of skin substitutes across four unique technology platforms...
11.11.25 - 22:37
FDA-Zulassung für Herzchirurgie-Gerät beflügelt Aktie von Integra LifeSciences (Investing.com DE)
 
Um den gesamten Artikel unter de.investing.com zu lesen, klicken Sie bitte auf die Überschrift...
11.11.25 - 22:18
Integra LifeSciences Receives FDA 510(k) Clearance for Use of the CUSA® Clarity Ultrasonic Surgical Aspirator System for Cardiac Surgeries (GlobeNewswire EN)
 
PRINCETON, N.J., Nov. 11, 2025 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq: IART), a leading global medical technology company, is pleased to announce the FDA 510(k) clearance for use of its CUSA® Clarity Ultrasonic Surgical Aspirator System for cardiac surgeries. The recent clearance for specific cardiac indications encompasses the debridement of unwanted tissue in cardiac surgeries, including valve replacement and repair....
07.11.25 - 05:01
Insiderhandel: Aufsichtsrat kauft Aktien von Integra LifeSciences Holdings im Wert von 102150 USD (Insiderkauf)
 
Graves, Jeffrey A. - Aufsichtsrat - Tag der Transaktion: 2025-11-05...
30.10.25 - 13:30
Integra LifeSciences (IART) Q3 Earnings Beat Estimates (Zacks)
 
Integra (IART) delivered earnings and revenue surprises of +25.58% and -3.07%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?...
30.10.25 - 11:18
Integra LifeSciences Holdings Corporation Non-GAAP EPS of $0.54 beats by $0.11, revenue of $402.06M misses by $12.25M (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
30.10.25 - 11:03
Integra LifeSciences Reports Third Quarter 2025 Financial Results (GlobeNewswire EN)
 
PRINCETON, N.J., Oct. 30, 2025 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq: IART), a leading global medical technology company, today reported financial results for the third quarter ending September 30, 2025....
15.10.25 - 14:33
Integra LifeSciences to Host Third Quarter 2025 Financial Results Conference Call on October 30, 2025 (GlobeNewswire EN)
 
PRINCETON, N.J., Oct. 15, 2025 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq: IART), a leading global medical technology company, will release third quarter 2025 financial results on Thursday, October 30, 2025, prior to the market open. In conjunction with the earnings release, Integra's management team will host a conference call at 8:30 a.m. ET....
08.10.25 - 14:33
Integra LifeSciences to Spotlight Neurosurgical Product Portfolio at the Congress of Neurological Surgeons (CNS) Annual Meeting (GlobeNewswire EN)
 
Featuring Durepair® Dura Regeneration Matrix and Mayfield® Ghost™ Base Unit, Post Featuring Durepair® Dura Regeneration Matrix and Mayfield® Ghost™ Base Unit, Post...
22.09.25 - 15:09
Integra LifeSciences appoints new Chief Medical Officer (SeekingAlpha)
 
Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...
22.09.25 - 14:33
Integra LifeSciences Strengthens Leadership with Appointment of New Chief Medical Officer (GlobeNewswire EN)
 
Dr. Raymond Turner is a board-certified endovascular neurosurgeon with more than 20 years of surgical practice Dr. Raymond Turner is a board-certified endovascular neurosurgeon with more than 20 years of surgical practice...
>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!
Zitat des Tages: Notwendigkeit ist bei weitem stärker als die Kunst. - Aischylos
>Aktien | >Anleihen | >ETFs | >Fonds | >Branchen | >Länder | >Themen | >Redaktionen
Partner:    >TradegateBSX Börse | >Dukascopy | >TradingView | >Boersentreff- Partner

Börsentreff auf Facebook | Börsentreff auf X | Börsentreff auf Instagram

Copyright @ Boersentreff.de - Die Märkte im Blick!